Liquidia Corp (LQDA)
Liquidia Corp (LQDA) from its SEC filings: 2025 revenue $158.3 million (+1031% vs the year before), net margin -44%, free cash flow -$40.0 million. Insider trades, recent filings and a price chart. Free.
| Exchange | Nasdaq |
| Industry | Pharmaceutical Preparations |
| Revenue (2025) | $158.3 million |
| Revenue growth | +1031% |
| Net income | -$68.9 million |
| Net margin | -43.5% |
| Free cash flow | -$40.0 million |
| Diluted EPS | $-0.80 |
| Latest quarter (Q2 2026 (calendar)) revenue vs a year earlier | +1843% |
| Cash | $284.2 million |
| Long-term debt | $19.9 million |
| Share count, 1 year | +4% |
| Fundamentals check | Mixed fundamentals |
Source: SEC EDGAR company filings (XBRL), updated 2026-10-23. Education only, not financial advice.